Search results
Showing 331 to 345 of 1308 results for social care
Our guidance helps you hand over care and ensure people are safely transitioned out of the virtual ward environment.
This quality standard covers testing, diagnosing and managing hepatitis B in adults, young people and children (from birth). It describes high-quality care in priority areas for improvement.
View quality statements for QS65Show all sections
Sections for QS65
- Quality statements
- Quality statement 1: Testing and vaccination for hepatitis B
- Quality statement 2: Referral for specialist care
- Quality statement 3: Referral to and assessment by specialist care for pregnant women who are identified as hepatitis B surface antigen-positive at antenatal screening
- Quality statement 4: Complete course of neonatal hepatitis B vaccination and blood testing at 12 months
- Quality statement 5: Personalised care plan
- Quality statement 6: Monitoring people with chronic hepatitis B infection who do not meet the criteria for antiviral treatment
- Quality statement 7: 6-monthly surveillance testing for hepatocellular carcinoma in adults with chronic hepatitis B infection who have significant liver fibrosis or cirrhosis
Read NICE's patient and public involvement policy.
Read NICE's patient and public involvement policy.
In development Reference number: GID-TA11186 Expected publication date: TBC
and approaches for gathering the experiences of people who use adult social care services:- When conducting research for the purposes of...
share the same mission: helping practitioners and commissioners get the best care to patients fast, while ensuring value for the...
NG58/3 Question Costing tool:- Which elements of health, social care or other support services work best at a local level and provide...
(QOF). 2010 First quality standard QS1 Dementia: support in health and social care (March). Read more about quality standards . First...
The guidance development timeline
This quality standard covers assessing and managing oesophago-gastric cancer in adults. It describes high-quality care in priority areas for improvement.
Teprotumumab for treating thyroid eye disease (deferred appraisal of D1) [ID6756]
In development Reference number: GID-TA11995 Expected publication date: 08 October 2026
People have the right to be able to make informed decisions about their care. Our guidance should be taken into account when making decisions with them.
This quality standard covers the clinical care of adults (aged 18 and over) who are dying, during the last 2 to 3 days of life. It describes high-quality care in priority areas for improvement.
member of one of our committees who has personal experience of using health or care services. The phrase could also refer to someone...